Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01438476 · ClinicalTrials.gov registry record · Phase 3
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas
A Phase 3 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 178
- Enrollment target
NCT01438476: Completed Phase 3 study, sponsored by M.D. Anderson Cancer Center.
NCT01438476 is a Phase 3 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01438476, a Phase 3 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 178 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if there is a difference in patients' quality of recovery if they receive 1 of 2 standard kinds of pain control treatments after surgery on the liver and/or pancreas. Researchers want to learn which method helps people to recover more completely and more quickly after surgery. The 2 kinds of pain control are intravenous (IV) pain management and epidural pain management.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Intravenous Patient-Controlled Analgesia (IVPCA)
- PROCEDURE Thoracic Epidural Analgesia (TEA)
- BEHAVIORAL Pain Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2012-01-26 |
| Est. Completion | 2017-10-18 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01438476
The ClinicalTrials.gov registry entry for NCT01438476 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT01438476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01438476 about?
NCT01438476 is a clinical study titled "Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas". The goal of this clinical research study is to learn if there is a difference in patients' quality of recovery if they receive 1 of 2 standard kinds of pain control treatments after surgery on the liver and/or pancreas. Researchers want to learn which method helps people to recover more completely a...
What is the current status of trial NCT01438476?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 178 participants. The study started on 2012-01-26. Estimated completion is 2017-10-18.
What interventions are being tested in trial NCT01438476?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Intravenous Patient-Controlled Analgesia (IVPCA) (PROCEDURE), Thoracic Epidural Analgesia (TEA) (PROCEDURE), Pain Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01438476?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.